XML 24 R13.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Other Financial Data
3 Months Ended
Mar. 31, 2024
Other Financial Data [Abstract]  
Other Financial Data

5. Other Financial Data

Condensed Consolidated Balance Sheets Information

Receivables, net

The components of Receivables, net are as follows (in millions):

 

 

 

March 31,

 

 

 

December 31,

 

 

 

2024

 

 

 

2023

 

Billed and unbilled receivables

 

$

 

399

 

 

 

$

 

442

 

Allowance for expected credit losses

 

 

 

(6

)

 

 

 

 

(7

)

Balance at end of period

 

$

 

393

 

 

 

$

 

435

 

 

Other current assets

The components of Other current assets are as follows (in millions):

 

 

 

March 31,

 

 

 

December 31,

 

 

 

2024

 

 

 

2023

 

Deferred project costs

 

$

 

22

 

 

 

$

 

20

 

Prepaid expenses

 

 

 

43

 

 

 

 

 

48

 

Commissions receivable

 

 

 

66

 

 

 

 

 

107

 

Other

 

 

 

86

 

 

 

 

 

85

 

Total

 

$

 

217

 

 

 

$

 

260

 

 

Other assets

The components of Other assets are as follows (in millions):

 

 

 

March 31,

 

 

 

December 31,

 

 

 

2024

 

 

 

2023

 

Deferred project costs

 

$

 

242

 

 

 

$

 

240

 

Operating lease right of use asset

 

 

 

56

 

 

 

 

 

55

 

Commissions receivable

 

 

 

20

 

 

 

 

 

22

 

Other

 

 

 

28

 

 

 

 

 

24

 

Total

 

$

 

346

 

 

 

$

 

341

 

 

The current and non-current portions of deferred project costs relate to costs to obtain and fulfill contracts (see Note 3 “Revenue from Contracts with Customers”). Total amortization expense related to deferred project costs for each of the three months ended March 31, 2024 and 2023 were $6 million, and are recorded in Cost of services, exclusive of depreciation and amortization in the accompanying Condensed Consolidated Statements of Comprehensive Income (Loss).

Other current assets and Other assets include the fair value of outstanding derivative instruments related to interest rate swaps. The balances in Other current assets as of March 31, 2024 and December 31, 2023 were $56 million and $60 million, respectively. The balances in Other assets as of March 31, 2024 and December 31, 2023 were $21 million and $17 million, respectively (see Note 13 “Derivative Financial Instruments” for additional information).

Other current liabilities

The components of Other current liabilities are as follows (in millions):

 

 

 

March 31,

 

 

 

December 31,

 

 

 

2024

 

 

 

2023

 

Deferred revenue

 

$

 

87

 

 

 

$

 

97

 

Operating lease liabilities

 

 

 

28

 

 

 

 

 

27

 

Finance lease liabilities

 

 

 

22

 

 

 

 

 

10

 

Other

 

 

 

145

 

 

 

 

 

99

 

Total

 

$

 

282

 

 

 

$

 

233

 

 

Other liabilities

The components of Other liabilities are as follows (in millions):

 

 

 

March 31,

 

 

 

December 31,

 

 

 

2024

 

 

 

2023

 

Deferred revenue

 

$

 

45

 

 

 

$

 

45

 

Operating lease liabilities

 

 

 

62

 

 

 

 

 

65

 

Finance lease liabilities

 

 

 

40

 

 

 

 

 

6

 

Other

 

 

 

19

 

 

 

 

 

26

 

Total

 

$

 

166

 

 

 

$

 

142

 

 

The current and non-current portions of deferred revenue relates to consideration received in advance of performance under client contracts. During the three months ended March 31, 2024 and 2023, revenue of approximately $77 million and $64 million was recognized that was recorded as deferred revenue at the beginning of each period, respectively.

Other current liabilities as of March 31, 2024 and December 31, 2023, included the current portion of tax receivable agreement liability of $89 million and $62 million, respectively (see Note 15 "Tax Receivable Agreement" for additional information).

Other current liabilities and Other liabilities include the fair value of outstanding derivative instruments related to interest rate swaps. There were no interest rate swaps recorded in Other current liabilities as of both March 31, 2024 and December 31, 2023 (see Note 13 “Derivative Financial Instruments” for additional information).